Division 5.8.3 Endocrine disrupting properties

If there is evidence that the active substance may have endocrine disrupting properties, additional information or specific studies shall be required:

• to elucidate the mode/mechanism of action,

• to provide sufficient evidence for relevant adverse effects.

Studies required shall be designed on an individual basis and taking into account F1national or internationally agreed guidelines, in the light of the particular parameters to be investigated and the objectives to be achieved.